Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy

Published:2015-11 Issue: Volume:70 Page:71-83
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Shen Song,Sun Chun-Yang,Du Xiao-Jiao,Li Hong-Jun,Liu Yang,Xia Jin-Xing,Zhu Yan-Hua,Wang Jun

Funder

National Basic Research Program of China

National Natural Science Foundation of China

National High Technology Research and Development Program of China

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference60 articles.

1. Cancer statistics, 2015;Siegel;Ca Cancer J. Clin.,2015

2. Hepatocellular carcinoma;Tsochatzis;N. Engl. J. Med.,2012

3. Treatment of hepatocellular carcinoma: steps forward but still a long way to go;Mlynarsky;World J. Hepatol.,2015

4. Diagnosis and treatment of hepatocellular carcinoma;El-Serag;Gastroenterology,2008

5. Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies;Olsen;Ther. Adv. Gastroenterol.,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy;Journal of Controlled Release;2023-09

2. Nanomedicine strategies to counteract cancer stemness and chemoresistance;Exploration of Targeted Anti-tumor Therapy;2023-08-30

3. Liposome-Based Carriers for CRISPR Genome Editing;International Journal of Molecular Sciences;2023-08-16

4. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022;European Journal of Medicinal Chemistry;2022-12

5. Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options;Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3